Serena Williams is championing GLP-1 drugs for weight loss after having trouble shedding pounds following the birth of her ...

C-store retailers answer this Rovertown ‘hot, or not’ question as well others on GLP-1, Gen Zers and more at Outlook Leadership ...

Dr. Sterling Elliott, Clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School ...

Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.

Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions ...

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Serena Williams broke her silence about her weight loss journey, revealing she used medication to help her lose 31 pounds.

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...